Kanters Steve, Nansubuga Margaret, Mwehire Daniel, Odiit Mary, Kasirye Margaret, Musoke William, Druyts Eric, Yaya Sanni, Funk Anna, Ford Nathan, Mills Edward J
Faculty of Health Science, Simon Fraser University, Burnaby, BC, Canada ; Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada.
HIV AIDS (Auckl). 2013 May 29;5:111-9. doi: 10.2147/HIV.S42521. Print 2013.
We aimed to assess the relationship between gender and survival among adult patients newly enrolled on antiretroviral therapy (ART) in Uganda. We also specifically examined the role of antenatal services in favoring women's access to HIV care.
From an observational cohort study, we assessed survival and used logistic regression and differences in means to compare men and women who did not access care through antenatal services. Differences were assessed on measures of disease progression (WHO stage and CD4 count) and demographic (age, marital status, and education), behavioral (sexual activity, disclosure to partner, and testing), and clinical variables (hepatitis B and C, syphilis, malaria, and anemia). A mediational analysis that considered gender as the initial variable, time to death as the outcome, initial CD4 count as the mediator, and age as a covariate was performed using an accelerated failure time model with a Weibull distribution.
Between 2004 and 2011, a total of 4775 patients initiated ART, and after exclusions 4537 (93.2%) were included in analysis. Men initiating ART were more likely to have a WHO disease stage III or IV (odds ratio: 1.46, 95% confidence interval [CI]: 1.29-1.66), and lower CD4 cell counts compared to women (median baseline CD4 124 cells/mm(3), interquartile range [IQR]: 43-205 versus 147 cells/mm(3), IQR: 68-212, P-value < 0.0001). Men were at an increased risk of death compared to women (hazard ratio: 1.38, 95% CI: 1.03-1.83). Baseline CD4 cell counts accounted for 43% of the increased risk of death in men (95% CI: 22%-113%). Access to care via antenatal services did not explain differences in outcomes.
In this cohort there is a marked increase in risk of mortality for men and approximately half of it can be attributed to their later engagement in care. More effort is required to engage men in care in a timely manner.
我们旨在评估乌干达新接受抗逆转录病毒治疗(ART)的成年患者中性别与生存之间的关系。我们还特别研究了产前服务在促进女性获得HIV治疗方面的作用。
在一项观察性队列研究中,我们评估了生存情况,并使用逻辑回归和均值差异来比较未通过产前服务获得治疗的男性和女性。在疾病进展指标(世界卫生组织(WHO)分期和CD4细胞计数)以及人口统计学指标(年龄、婚姻状况和教育程度)、行为指标(性活动、向伴侣披露病情和检测)和临床变量(乙型和丙型肝炎、梅毒、疟疾和贫血)方面评估差异。使用具有威布尔分布的加速失效时间模型进行中介分析,将性别作为初始变量,死亡时间作为结果,初始CD4细胞计数作为中介,年龄作为协变量。
2004年至2011年期间,共有4775名患者开始接受ART治疗,排除后4537名(93.2%)纳入分析。与女性相比,开始接受ART治疗的男性更有可能处于WHO疾病III期或IV期(比值比:1.46,95%置信区间[CI]:1.29 - 1.66),且CD4细胞计数更低(基线CD4细胞计数中位数为124个/mm³,四分位间距[IQR]:43 - 205,而女性为147个/mm³,IQR:68 - 212,P值<0.0001)。与女性相比,男性死亡风险增加(风险比:1.38,95%CI:1.03 - 1.83)。基线CD4细胞计数占男性死亡风险增加的43%(95%CI:22% - 113%)。通过产前服务获得治疗并不能解释结局的差异。
在这个队列中,男性的死亡风险显著增加,其中约一半可归因于他们较晚接受治疗。需要做出更多努力,促使男性及时接受治疗。